NCT00150553View on ClinicalTrials.gov

Efficacy and Safety of SPD417 in Treatment of Manic Symptoms in Adults With Bipolar I Disorder

PHASE3CompletedINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

January 31, 2005

Study Completion Date

October 31, 2005

Conditions
Bipolar Disorder
Interventions
DRUG

Extended-release carbamazepine

Sponsors
All Listed Sponsors
lead

Validus Pharmaceuticals

INDUSTRY